Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03016572 · ClinicalTrials.gov registry record · NA
Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for Suicide
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03016572: Completed NA study, sponsored by The Cleveland Clinic.
NCT03016572 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03016572, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
This research study is designed to answer specific questions about new ways to provide services for youth at-risk of suicide.
Primary Outcome
Frequency of repeat suicide attempts during the 12 month follow up
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Crisis Intervention
- BEHAVIORAL Wraparound Services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-05-04 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
What the finished NCT03016572 record still lists
NCT03016572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT03016572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03016572 about?
NCT03016572 is a clinical study titled "Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for Suicide". This research study is designed to answer specific questions about new ways to provide services for youth at-risk of suicide.
What is the current status of trial NCT03016572?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2017-05-04. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT03016572?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Crisis Intervention (BEHAVIORAL), Wraparound Services (BEHAVIORAL).
Who is sponsoring clinical trial NCT03016572?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03016572's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI